Search research articles
Contact Us
Filters
Showing results (111-120 of 350) with videos related to
Page
of 35
Sort By:
Deutsche Medizinische Wochenschrift (1946)
|
July 15, 1977
[Acute myeloid leukaemia in the course of Hodgkin's disease (author's transl)]
F Cavalli, A Gerber, W Mosimann, et al.
Cancer Treatment Reports
|
September 1, 1976
Comparison of the biologic activity of VP-16-213 given iv and orally in capsules or drink ampules
K W Brunner, R W Sonntag, H J Ryssel, et al.
European Journal of Cancer & Clinical Oncology
|
March 1, 1984
Phase II study of doxifluridine in advanced squamous cell carcinoma of the head and neck
R Abele, E Kaplan, R Grossenbacher, et al.
Schweizerische Medizinische Wochenschrift
|
November 24, 1990
[Adjuvant systemic therapy in breast carcinoma in the 1990s: status of things and open questions]
A Goldhirsch, H Neuenschwander, M Castiglione, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 1, 1994
Recent progress in B- and T-cell lymphomas
R P Gale, T A Waldmann, J O Armitage, et al.
Revue Medicale De La Suisse Romande
|
March 1, 1997
[Palliative home care in Tessin--an example: Lugano Hospice]
B Marx, H Neuenschwander, M L Meier, et al.
Haematology and Blood Transfusion
|
January 1, 1978
[Preliminary results of a continuous study protocol with adjuvant chemotherapy in primary operable breast carcinoma]
F Cavalli, F Jungi, P Alberto, et al.
Cancer Treatment Reports
|
October 1, 1977
Lack of severe hypotension with VP-16-213 administered directly lv
F Cavalli, R W Sonntag, H J Ryssel, et al.
Onkologie
|
April 1, 1989
ABLETOP, a well-tolerated, effective regimen for relapsing Hodgkin's disease. Swiss Group for Clinical Cancer Research (SAKK)
R Obrist, H P Honegger, M Aapro, et al.
European Journal of Cancer & Clinical Oncology
|
October 1, 1981
Phase II study of oral VP-16-213 in hepatocellular carcinoma
F Cavalli, M Rozencweig, J Renard, et al.
Page
of 35
Search research articles
Search
Showing results (111-120 of 350) with videos related to
Sort By:
Page
of 35
Deutsche Medizinische Wochenschrift (1946)
|
July 15, 1977
[Acute myeloid leukaemia in the course of Hodgkin's disease (author's transl)]
F Cavalli, A Gerber, W Mosimann, et al.
Cancer Treatment Reports
|
September 1, 1976
Comparison of the biologic activity of VP-16-213 given iv and orally in capsules or drink ampules
K W Brunner, R W Sonntag, H J Ryssel, et al.
European Journal of Cancer & Clinical Oncology
|
March 1, 1984
Phase II study of doxifluridine in advanced squamous cell carcinoma of the head and neck
R Abele, E Kaplan, R Grossenbacher, et al.
Schweizerische Medizinische Wochenschrift
|
November 24, 1990
[Adjuvant systemic therapy in breast carcinoma in the 1990s: status of things and open questions]
A Goldhirsch, H Neuenschwander, M Castiglione, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 1, 1994
Recent progress in B- and T-cell lymphomas
R P Gale, T A Waldmann, J O Armitage, et al.
Revue Medicale De La Suisse Romande
|
March 1, 1997
[Palliative home care in Tessin--an example: Lugano Hospice]
B Marx, H Neuenschwander, M L Meier, et al.
Haematology and Blood Transfusion
|
January 1, 1978
[Preliminary results of a continuous study protocol with adjuvant chemotherapy in primary operable breast carcinoma]
F Cavalli, F Jungi, P Alberto, et al.
Cancer Treatment Reports
|
October 1, 1977
Lack of severe hypotension with VP-16-213 administered directly lv
F Cavalli, R W Sonntag, H J Ryssel, et al.
Onkologie
|
April 1, 1989
ABLETOP, a well-tolerated, effective regimen for relapsing Hodgkin's disease. Swiss Group for Clinical Cancer Research (SAKK)
R Obrist, H P Honegger, M Aapro, et al.
European Journal of Cancer & Clinical Oncology
|
October 1, 1981
Phase II study of oral VP-16-213 in hepatocellular carcinoma
F Cavalli, M Rozencweig, J Renard, et al.
Page
of 35